Different immunosuppressants have their concerns: systemic glucocorticoids nonspecifically decrease the immune system and may have a negative impact on anti-tumor immunity, whereas TNF inhibitors can be worrisome to use for ICI-LE as they themselves can cause drug-induced lupus. Here, TNF is linked to neoplasm.